LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 190 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $239,000 | -12.8% | 2,400 | 0.0% | 0.33% | -8.2% |
| Q2 2019 | $274,000 | -9.3% | 2,400 | 0.0% | 0.36% | -9.7% |
| Q1 2019 | $302,000 | -40.6% | 2,400 | -52.0% | 0.40% | +24.0% |
| Q4 2016 | $508,000 | -28.9% | 5,000 | -28.6% | 0.32% | -29.3% |
| Q3 2016 | $714,000 | -0.3% | 7,000 | +16.7% | 0.46% | -4.6% |
| Q2 2016 | $716,000 | -4.5% | 6,000 | -14.3% | 0.48% | -7.3% |
| Q1 2016 | $750,000 | +38.4% | 7,000 | +40.0% | 0.52% | +42.1% |
| Q4 2015 | $542,000 | +26.6% | 5,000 | 0.0% | 0.37% | +19.6% |
| Q3 2015 | $428,000 | -47.0% | 5,000 | -37.5% | 0.31% | -41.6% |
| Q2 2015 | $807,000 | -4.8% | 8,000 | -27.3% | 0.52% | +40.9% |
| Q1 2015 | $848,000 | -11.5% | 11,000 | -38.9% | 0.37% | -12.9% |
| Q4 2014 | $958,000 | +13.2% | 18,000 | 0.0% | 0.43% | +8.9% |
| Q3 2014 | $846,000 | -9.4% | 18,000 | +20.0% | 0.39% | -8.6% |
| Q2 2014 | $934,000 | – | 15,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |